The cotton rat model of experimental human respiratory syncytial virus (RSV) infection was used to study the efficacy of FG, a novel chimeric glycoprotein which was expressed in insect cells using a baculovirus vector. FG contained the extracellular regions of the F (fusion) and G (attachment) glycoproteins of RSV. Vaccination with FG resulted in induction of neutralizing antibody and was correlated with protection of lung tissue from RSV challenge against both serogroup A and B virus strains. Both crude FG taken from supernatants of insect cells and affinity-purified FG were immunogenic and active against RSV. FG vaccination was effective by three routes of administration, following a single dose, and when administered with different adjuvants.
ElangoN.,
PrinceG. A.,
MurphyB. R.,
VenkatesanS.,
ChanockR. M.,
MossB.1986; Resistance to human respiratory syncytial virus -(RSV)infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proceedings of the National Academy of SciencesU.S.A831906–1910
KimH. W.,
ArrobioJ. O.,
PylesG.,
BrandtC. D.,
CamargoE.,
ChanockR. M.,
ParrottR. H.1971; Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatrics 58:745–755
MooreR. M.,
WaltersR. R.1984; Protein separations on reversed-phase high-performance liquid chromatography minicolumns. Journal of Chromatography 317:119–128
OlmstedR. A.,
ElangoN.,
PrinceG. A.,
MurphyB. R.,
JohnsonP. R.,
MossB.,
ChanockR. M.,
CollinsP. L.1986; Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proceedings of the National Academy of SciencesU.S.A. 837462–7466
ParrottR. H.,
KimH. W.,
ArrobioI. O.,
HodesD. S.,
MurphyB. R.,
BrandtC. D.,
CamargoE.,
ChanockR. M.1973; Epidemiology of respiratory syncytial virus infection in Washington, DC. II. Infection and disease with respect to age, immunological status, race, and sex. American Journal of Epidemiology 98:289–300
PetrovskisE. A.,
TimminsJ. G.,
ArmentroutM. A.,
MarchioliC. C.,
YanceyR. J.,
PostL. E.1986; DNA sequence of the gene for pseudorabies virus gp50, a glycoprotein without N-linked glycosylation. Journal of Virology 59:216–223
StottE. J.,
BallL. A.,
YoungK.,
FurzeJ.,
WertzG. W.1986; Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live virus challenge. Journal of Virology 60:607–613
WalshE. E.,
HallC. B.,
BriselliM.,
BrandrissM. W.,
SchlesingerJ. J.1987; Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. Journal of Infectious Diseases 155:1198–1204
WathenM. W.,
BrideauR. J.,
ThomsenD. R.1989a; Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector. Journal of Infectious Diseases 159:255–263
WathenM. W.,
BrideauR. J.,
ThomsenD. R.,
MurphyB. R.1989b; Characterization of a novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector. Journal of General Virology 70:2625–2635
WertzG. W.,
StottE. J.,
YoungK. Y.,
AndersonK.,
BallL. A.1987; Expression of the fusion protein of human respiratory syncytial mice. Journal of Virology 61:193–301
WrightP. F.,
BelsheR. B.,
KimH. W., van VorisL. P.,
ChanockR. M.1982; Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infection and Immunity 37:397–400